• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胱抑素 D(CST5):创伤性脑损伤的超早期炎症生物标志物。

Cystatin D (CST5): An ultra-early inflammatory biomarker of traumatic brain injury.

机构信息

Neuroscience & Ophthalmology Research Group, Institute of Inflammation & Ageing, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, B15 2TT, Birmingham, UK.

National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre, Queen Elizabeth Hospital, Edgbaston, B15 2TH, Birmingham, UK.

出版信息

Sci Rep. 2017 Jul 10;7(1):5002. doi: 10.1038/s41598-017-04722-5.

DOI:10.1038/s41598-017-04722-5
PMID:28694499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5504020/
Abstract

Traumatic brain injury (TBI) is set to become the leading cause of neurological disability across all age groups. Currently, no reliable biomarkers exist to help diagnose the severity of TBI to identify patients who are at risk of developing secondary injuries. Thus, the discovery of reliable biomarkers for the management of TBI would improve clinical interventions. Inflammatory markers are particularly suited for biomarker discovery as TBI leads to very early alterations in inflammatory proteins. Using the Proseek Multiplex Inflammation assay, we measured in patients that had suffered mild TBI (n = 10) or severe TBI (n = 10) with extra-cranial injury or extracranial injury only (EC) (n = 10), 92 inflammation-associated proteins in serum obtained: <1 hr (within 1-hour), 4-12 hr and 48-72 hr post injury. Changes were compared to healthy volunteers (HV). Our results identified CST5, AXIN1 and TRAIL as novel early biomarkers of TBI. CST5 identified patients with severe TBI from all other cohorts and importantly was able to do so within the first hour of injury. AXIN1 and TRAIL were able to discriminate between TBI and HV at <1 hr. We conclude that CST5, AXIN1 and TRAIL are worthy of further study in the context of a pre-hospital or pitch-side test to detect brain injury.

摘要

创伤性脑损伤 (TBI) 将成为所有年龄段人群中导致神经残疾的主要原因。目前,尚无可靠的生物标志物可用于帮助诊断 TBI 的严重程度,以确定有发生继发性损伤风险的患者。因此,发现可靠的 TBI 管理生物标志物将改善临床干预措施。炎症标志物特别适合用于生物标志物的发现,因为 TBI 会导致炎症蛋白的早期改变。我们使用 Proseek 多重炎症分析试剂盒,在有颅脑外损伤或仅有颅脑外损伤的轻度 TBI 患者(n=10)或重度 TBI 患者(n=10)中测量了发病后 1 小时内(<1 小时)、4-12 小时和 48-72 小时获得的血清中 92 种与炎症相关的蛋白。将结果与健康志愿者 (HV) 进行比较。我们的结果确定 CST5、AXIN1 和 TRAIL 为 TBI 的新型早期生物标志物。CST5 能够将重度 TBI 患者与其他所有队列区分开来,而且重要的是,它能够在受伤后 1 小时内完成。AXIN1 和 TRAIL 能够在<1 小时内区分 TBI 和 HV。我们得出结论,CST5、AXIN1 和 TRAIL 值得进一步研究,以用于在院前或场边测试中检测脑损伤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c24e/5504020/a3cd9a4c591f/41598_2017_4722_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c24e/5504020/152e2cdc675f/41598_2017_4722_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c24e/5504020/a3cd9a4c591f/41598_2017_4722_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c24e/5504020/152e2cdc675f/41598_2017_4722_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c24e/5504020/a3cd9a4c591f/41598_2017_4722_Fig2_HTML.jpg

相似文献

1
Cystatin D (CST5): An ultra-early inflammatory biomarker of traumatic brain injury.胱抑素 D(CST5):创伤性脑损伤的超早期炎症生物标志物。
Sci Rep. 2017 Jul 10;7(1):5002. doi: 10.1038/s41598-017-04722-5.
2
MicroRNAs as Novel Biomarkers for the Diagnosis and Prognosis of Mild and Severe Traumatic Brain Injury.微小RNA作为轻度和重度创伤性脑损伤诊断及预后的新型生物标志物
J Neurotrauma. 2017 Jun 1;34(11):1948-1956. doi: 10.1089/neu.2016.4857. Epub 2017 Apr 10.
3
Metabolomics and Biomarker Discovery in Traumatic Brain Injury.创伤性脑损伤的代谢组学和生物标志物发现。
J Neurotrauma. 2018 Aug 15;35(16):1831-1848. doi: 10.1089/neu.2017.5326.
4
An update on diagnostic and prognostic biomarkers for traumatic brain injury.创伤性脑损伤的诊断和预后生物标志物的最新研究进展。
Expert Rev Mol Diagn. 2018 Feb;18(2):165-180. doi: 10.1080/14737159.2018.1428089. Epub 2018 Jan 23.
5
Characterization and standardization of multiassay platforms for four commonly studied traumatic brain injury protein biomarkers: a TBI Endpoints Development Study.四种常见的外伤性脑损伤蛋白生物标志物的多分析平台的特征描述和标准化:一项 TBI 终点发展研究。
Biomark Med. 2021 Dec;15(18):1721-1732. doi: 10.2217/bmm-2021-0284. Epub 2021 Oct 22.
6
Prognostic Value of Serially Estimated Serum Procalcitonin Levels in Traumatic Brain Injury Patients With or Without Extra Cranial Injury on Early In-hospital Mortality: A Longitudinal Observational Study.血清降钙素原水平对伴或不伴颅外损伤的创伤性脑损伤患者早期住院病死率的预测价值:一项纵向观察性研究。
Neurocrit Care. 2021 Feb;34(1):182-192. doi: 10.1007/s12028-020-01009-y.
7
Monitoring of Protein Biomarkers of Inflammation in Human Traumatic Brain Injury Using Microdialysis and Proximity Extension Assay Technology in Neurointensive Care.在神经重症监护中使用微透析和临近延伸分析技术监测人类创伤性脑损伤中的炎症蛋白生物标志物。
J Neurotrauma. 2019 Oct 15;36(20):2872-2885. doi: 10.1089/neu.2018.6320. Epub 2019 Jun 17.
8
Characterisation of serum total tau following paediatric traumatic brain injury: a case-control study.儿童创伤性脑损伤后血清总tau 的特征:病例对照研究。
Lancet Child Adolesc Health. 2019 Aug;3(8):558-567. doi: 10.1016/S2352-4642(19)30194-4. Epub 2019 Jun 21.
9
UCH-L1 is a Poor Serum Biomarker of Murine Traumatic Brain Injury After Polytrauma.UCH-L1 是一种较差的多创伤性脑损伤后小鼠创伤性脑损伤的血清生物标志物。
J Surg Res. 2019 Dec;244:63-68. doi: 10.1016/j.jss.2019.06.023. Epub 2019 Jul 3.
10
Exploring Serum Biomarkers for Mild Traumatic Brain Injury探索轻度创伤性脑损伤的血清生物标志物

引用本文的文献

1
Deciphering genetic causality between plasma BDNF and 91 circulating inflammatory proteins through bidirectional mendelian randomization.通过双向孟德尔随机化解析血浆脑源性神经营养因子(BDNF)与91种循环炎症蛋白之间的遗传因果关系。
Sci Rep. 2025 Mar 25;15(1):10312. doi: 10.1038/s41598-025-95546-1.
2
Proteomic and serologic assessments of responses to mRNA-1273 and BNT162b2 vaccines in human recipient sera.对人类受种者血清中mRNA-1273和BNT162b2疫苗反应的蛋白质组学和血清学评估。
Front Immunol. 2025 Jan 27;15:1502458. doi: 10.3389/fimmu.2024.1502458. eCollection 2024.
3
Plasma proteomic signature of neonates in the context of placental histological chorioamnionitis.

本文引用的文献

1
Serum neurofilament light protein predicts clinical outcome in traumatic brain injury.血清神经丝轻蛋白预测创伤性脑损伤的临床结局。
Sci Rep. 2016 Nov 7;6:36791. doi: 10.1038/srep36791.
2
Increases of Plasma Levels of Glial Fibrillary Acidic Protein, Tau, and Amyloid β up to 90 Days after Traumatic Brain Injury.创伤性脑损伤后长达90天,血浆中胶质纤维酸性蛋白、Tau蛋白和β淀粉样蛋白水平升高。
J Neurotrauma. 2017 Jan 1;34(1):66-73. doi: 10.1089/neu.2015.4333. Epub 2016 Jul 8.
3
Glial fibrillary acidic protein as a biomarker in severe traumatic brain injury patients: a prospective cohort study.
胎盘组织学绒毛膜羊膜炎背景下新生儿的血浆蛋白质组学特征。
BMJ Paediatr Open. 2024 Sep 4;8(1):e002708. doi: 10.1136/bmjpo-2024-002708.
4
Causal Relationships Between Circulating Inflammatory Proteins and Obstructive Sleep Apnea: A Bidirectional Mendelian Randomization Study.循环炎症蛋白与阻塞性睡眠呼吸暂停之间的因果关系:一项双向孟德尔随机化研究
Nat Sci Sleep. 2024 Jun 13;16:787-800. doi: 10.2147/NSS.S458637. eCollection 2024.
5
Inflammatory cytokines and their potential role in kidney stone disease: a Mendelian randomization study.炎症细胞因子及其在肾结石病中的潜在作用:一项孟德尔随机研究。
Int Urol Nephrol. 2024 Oct;56(10):3249-3257. doi: 10.1007/s11255-024-04084-8. Epub 2024 May 22.
6
Immune cell signatures and inflammatory mediators: unraveling their genetic impact on chronic kidney disease through Mendelian randomization.免疫细胞特征和炎症介质:通过孟德尔随机化揭示它们对慢性肾脏病的遗传影响。
Clin Exp Med. 2024 May 4;24(1):94. doi: 10.1007/s10238-024-01341-z.
7
The Immune Signature of CSF in Multiple Sclerosis with and without Oligoclonal Bands: A Machine Learning Approach to Proximity Extension Assay Analysis.多发性硬化症伴或不伴寡克隆带的脑脊液免疫特征:一种接近延伸分析的机器学习方法。
Int J Mol Sci. 2023 Dec 21;25(1):139. doi: 10.3390/ijms25010139.
8
Screening for Circulating Inflammatory Proteins Does Not Reveal Plasma Biomarkers of Constant Tinnitus.筛查循环炎症蛋白并未揭示恒定耳鸣的血浆生物标志物。
J Assoc Res Otolaryngol. 2023 Dec;24(6):593-606. doi: 10.1007/s10162-023-00920-3. Epub 2023 Dec 11.
9
Potential Biomarkers in Experimental Animal Models for Traumatic Brain Injury.创伤性脑损伤实验动物模型中的潜在生物标志物
J Clin Med. 2023 Jun 8;12(12):3923. doi: 10.3390/jcm12123923.
10
Targeted plasma proteomics reveals upregulation of distinct inflammatory pathways in people living with HIV.靶向血浆蛋白质组学揭示了HIV感染者中不同炎症途径的上调。
iScience. 2022 Sep 7;25(10):105089. doi: 10.1016/j.isci.2022.105089. eCollection 2022 Oct 21.
胶质纤维酸性蛋白作为重度创伤性脑损伤患者的生物标志物:一项前瞻性队列研究。
Crit Care. 2015 Oct 12;19:362. doi: 10.1186/s13054-015-1081-8.
4
Cystatin D locates in the nucleus at sites of active transcription and modulates gene and protein expression.胱抑素D定位于活跃转录位点的细胞核中,并调节基因和蛋白质表达。
J Biol Chem. 2015 Oct 30;290(44):26533-48. doi: 10.1074/jbc.M115.660175. Epub 2015 Sep 13.
5
S100B and Glial Fibrillary Acidic Protein as Indexes to Monitor Damage Severity in an In Vitro Model of Traumatic Brain Injury.S100B和胶质纤维酸性蛋白作为监测创伤性脑损伤体外模型损伤严重程度的指标
Neurochem Res. 2015 May;40(5):991-9. doi: 10.1007/s11064-015-1554-9. Epub 2015 Apr 22.
6
Neuroinflammatory responses to traumatic brain injury: etiology, clinical consequences, and therapeutic opportunities.创伤性脑损伤的神经炎症反应:病因、临床后果及治疗机遇。
Neuropsychiatr Dis Treat. 2015 Jan 8;11:97-106. doi: 10.2147/NDT.S65815. eCollection 2015.
7
Blood-based biomarkers for traumatic brain injury: evaluation of research approaches, available methods and potential utility from the clinician and clinical laboratory perspectives.创伤性脑损伤的血液生物标志物:从临床医生和临床实验室角度评估研究方法、现有方法及潜在应用价值
Clin Biochem. 2014 Jul;47(10-11):876-88. doi: 10.1016/j.clinbiochem.2014.01.028. Epub 2014 Jan 31.
8
Biomarkers for the clinical differential diagnosis in traumatic brain injury--a systematic review.创伤性脑损伤的临床鉴别诊断生物标志物——系统评价。
CNS Neurosci Ther. 2013 Aug;19(8):556-65. doi: 10.1111/cns.12127. Epub 2013 May 27.
9
The role of markers of inflammation in traumatic brain injury.炎症标志物在创伤性脑损伤中的作用。
Front Neurol. 2013 Mar 4;4:18. doi: 10.3389/fneur.2013.00018. eCollection 2013.
10
Acute minocycline treatment mitigates the symptoms of mild blast-induced traumatic brain injury.急性米诺环素治疗可减轻轻度爆炸所致创伤性脑损伤的症状。
Front Neurol. 2012 Jul 16;3:111. doi: 10.3389/fneur.2012.00111. eCollection 2012.